Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Current Oncology (Toronto, Ont.)
|
August 27, 2025
Lung Carcinoids in Adolescents and Young Adults (AYAs): A Still Overlooked Clinical Entity
Alice Laffi, Laura Pala, Chiara Catania, et al.
Current Oncology (Toronto, Ont.)
|
October 28, 2025
Bridging Knowledge Gaps in Small Cell Lung Cancer: Data, Challenges and Priorities
Chiara Catania, Priscilla Cascetta, Alessandro Russo, et al.
Journal of Translational Medicine
|
July 31, 2024
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung)
Fabrizio Citarella, Kazuki Takada, Priscilla Cascetta, et al.
Journal of Chemotherapy (Florence, Italy)
|
August 6, 2024
Induction chemotherapy backbone in frail patients with advanced NSCLC treated with chemotherapy plus pembrolizumab: a single institution retrospective audit of dose intensities from modified regimens
Alessio Cortellini, Fabrizio Citarella, Alessia Vendittelli, et al.
Cancers
|
October 14, 2022
BRAF Inhibitors in Non-Small Cell Lung Cancer
Vincenzo Sforza, Giuliano Palumbo, Priscilla Cascetta, et al.
Cancers
|
September 10, 2021
RET Inhibitors in Non-Small-Cell Lung Cancer
Priscilla Cascetta, Vincenzo Sforza, Anna Manzo, et al.
Therapeutic Advances in Medical Oncology
|
October 16, 2020
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules
Francesca Foschini, Fabiana Napolitano, Alberto Servetto, et al.
JNCI Cancer Spectrum
|
August 20, 2025
Heterogeneity of progression-free-survival surrogacy by sex in randomized trials testing immunotherapy in NSCLC
Eleonora Pagan, Isabella Sala, Laura Pala, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 1, 2026
Family history enrichment in Non-Small cell Lung Cancer: A cross-sectional - prospective study to inform referral for germline testing
Fabrizio Citarella, Francesco M Venanzi, Giulia Di Giovanni, et al.
Oncotarget
|
May 26, 2016
Everolimus induces Met inactivation by disrupting the FKBP12/Met complex
Lucia Raimondo, Valentina D'Amato, Alberto Servetto, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Current Oncology (Toronto, Ont.)
|
August 27, 2025
Lung Carcinoids in Adolescents and Young Adults (AYAs): A Still Overlooked Clinical Entity
Alice Laffi, Laura Pala, Chiara Catania, et al.
Current Oncology (Toronto, Ont.)
|
October 28, 2025
Bridging Knowledge Gaps in Small Cell Lung Cancer: Data, Challenges and Priorities
Chiara Catania, Priscilla Cascetta, Alessandro Russo, et al.
Journal of Translational Medicine
|
July 31, 2024
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung)
Fabrizio Citarella, Kazuki Takada, Priscilla Cascetta, et al.
Journal of Chemotherapy (Florence, Italy)
|
August 6, 2024
Induction chemotherapy backbone in frail patients with advanced NSCLC treated with chemotherapy plus pembrolizumab: a single institution retrospective audit of dose intensities from modified regimens
Alessio Cortellini, Fabrizio Citarella, Alessia Vendittelli, et al.
Cancers
|
October 14, 2022
BRAF Inhibitors in Non-Small Cell Lung Cancer
Vincenzo Sforza, Giuliano Palumbo, Priscilla Cascetta, et al.
Cancers
|
September 10, 2021
RET Inhibitors in Non-Small-Cell Lung Cancer
Priscilla Cascetta, Vincenzo Sforza, Anna Manzo, et al.
Therapeutic Advances in Medical Oncology
|
October 16, 2020
FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules
Francesca Foschini, Fabiana Napolitano, Alberto Servetto, et al.
JNCI Cancer Spectrum
|
August 20, 2025
Heterogeneity of progression-free-survival surrogacy by sex in randomized trials testing immunotherapy in NSCLC
Eleonora Pagan, Isabella Sala, Laura Pala, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 1, 2026
Family history enrichment in Non-Small cell Lung Cancer: A cross-sectional - prospective study to inform referral for germline testing
Fabrizio Citarella, Francesco M Venanzi, Giulia Di Giovanni, et al.
Oncotarget
|
May 26, 2016
Everolimus induces Met inactivation by disrupting the FKBP12/Met complex
Lucia Raimondo, Valentina D'Amato, Alberto Servetto, et al.
Page
of 2